Methylmercury inhibits cysteine uptake in cultured primary astrocytes, but not in neurons

Gouri Shanker, Jeffrey W. Allen, Lysette A. Mutkus, Michael Aschner

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

The maintenance of adequate intracellular glutathione (GSH) concentrations is dependent on the availability and transport of the rate-limiting substrate, cysteine. A suggested mechanism of methylmercury (MeHg) neurotoxicity in brain involves the formation of oxygen radicals, and a decrease in intracellular levels of GSH. Recently, we have characterized various cysteine transport systems (both Na+-dependent and -independent) in cerebrocortical astrocytes and hippocampal neurons. The present study was carried out to investigate the effect of MeHg on cysteine uptake in both astrocytes and neurons, and to determine whether cysteine transport is differentially affected in the two cell types by MeHg treatment. Sixty-minute pretreatment with MeHg caused significant concentration-dependent inhibition in cysteine uptake in astrocytes, but not in neurons. As most of the cysteine transport is Na+-dependent (80-90% of total), additional studies focused on MeHg's effect on the Na+-dependent cysteine transporters XAG- and ASC. An additive inhibitory effect on cysteine uptake was observed in astrocytes treated with MeHg (5 μM) plus sub-maximal inhibitory concentrations (0.1 and 0.5 mM) of threo-β-hydroxy-aspartate (THA), a specific inhibitor of the Na+-dependent transporter, XAG-, compared to astrocytes treated with MeHg (P<0.001) or THA alone (P<0.05). There was no additive effect of MeHg and maximal inhibitory concentrations of THA (1.0 and 5.0 mM) on astrocytic cysteine uptake inhibition. Additional studies examined the sensitivity of the Na+-dependent ASC transport system to MeHg treatment. Maximal inhibitory concentration of L-serine (10 mM) alone had a rather modest inhibitory effect on cysteine uptake, and when applied in the presence of MeHg there was no additive effect. These results suggest that the inhibition of cysteine uptake by MeHg in astrocytes occurs through specific inhibition of both the XAG- as well as the ASC transport system.

Original languageEnglish (US)
Pages (from-to)159-165
Number of pages7
JournalBrain Research
Volume914
Issue number1-2
DOIs
StatePublished - Sep 28 2001
Externally publishedYes

Fingerprint

Astrocytes
Cysteine
Neurons
Aspartic Acid
methylmercury cysteine
Serine
Glutathione
Reactive Oxygen Species
Brain

Keywords

  • Astrocytes
  • Cysteine
  • Glutathione
  • In vitro
  • Methlmercury
  • Neurons
  • Transport

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Methylmercury inhibits cysteine uptake in cultured primary astrocytes, but not in neurons. / Shanker, Gouri; Allen, Jeffrey W.; Mutkus, Lysette A.; Aschner, Michael.

In: Brain Research, Vol. 914, No. 1-2, 28.09.2001, p. 159-165.

Research output: Contribution to journalArticle

Shanker, Gouri ; Allen, Jeffrey W. ; Mutkus, Lysette A. ; Aschner, Michael. / Methylmercury inhibits cysteine uptake in cultured primary astrocytes, but not in neurons. In: Brain Research. 2001 ; Vol. 914, No. 1-2. pp. 159-165.
@article{e6d0b0341db247159733c4a474f63dbb,
title = "Methylmercury inhibits cysteine uptake in cultured primary astrocytes, but not in neurons",
abstract = "The maintenance of adequate intracellular glutathione (GSH) concentrations is dependent on the availability and transport of the rate-limiting substrate, cysteine. A suggested mechanism of methylmercury (MeHg) neurotoxicity in brain involves the formation of oxygen radicals, and a decrease in intracellular levels of GSH. Recently, we have characterized various cysteine transport systems (both Na+-dependent and -independent) in cerebrocortical astrocytes and hippocampal neurons. The present study was carried out to investigate the effect of MeHg on cysteine uptake in both astrocytes and neurons, and to determine whether cysteine transport is differentially affected in the two cell types by MeHg treatment. Sixty-minute pretreatment with MeHg caused significant concentration-dependent inhibition in cysteine uptake in astrocytes, but not in neurons. As most of the cysteine transport is Na+-dependent (80-90{\%} of total), additional studies focused on MeHg's effect on the Na+-dependent cysteine transporters XAG- and ASC. An additive inhibitory effect on cysteine uptake was observed in astrocytes treated with MeHg (5 μM) plus sub-maximal inhibitory concentrations (0.1 and 0.5 mM) of threo-β-hydroxy-aspartate (THA), a specific inhibitor of the Na+-dependent transporter, XAG-, compared to astrocytes treated with MeHg (P<0.001) or THA alone (P<0.05). There was no additive effect of MeHg and maximal inhibitory concentrations of THA (1.0 and 5.0 mM) on astrocytic cysteine uptake inhibition. Additional studies examined the sensitivity of the Na+-dependent ASC transport system to MeHg treatment. Maximal inhibitory concentration of L-serine (10 mM) alone had a rather modest inhibitory effect on cysteine uptake, and when applied in the presence of MeHg there was no additive effect. These results suggest that the inhibition of cysteine uptake by MeHg in astrocytes occurs through specific inhibition of both the XAG- as well as the ASC transport system.",
keywords = "Astrocytes, Cysteine, Glutathione, In vitro, Methlmercury, Neurons, Transport",
author = "Gouri Shanker and Allen, {Jeffrey W.} and Mutkus, {Lysette A.} and Michael Aschner",
year = "2001",
month = "9",
day = "28",
doi = "10.1016/S0006-8993(01)02791-3",
language = "English (US)",
volume = "914",
pages = "159--165",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Methylmercury inhibits cysteine uptake in cultured primary astrocytes, but not in neurons

AU - Shanker, Gouri

AU - Allen, Jeffrey W.

AU - Mutkus, Lysette A.

AU - Aschner, Michael

PY - 2001/9/28

Y1 - 2001/9/28

N2 - The maintenance of adequate intracellular glutathione (GSH) concentrations is dependent on the availability and transport of the rate-limiting substrate, cysteine. A suggested mechanism of methylmercury (MeHg) neurotoxicity in brain involves the formation of oxygen radicals, and a decrease in intracellular levels of GSH. Recently, we have characterized various cysteine transport systems (both Na+-dependent and -independent) in cerebrocortical astrocytes and hippocampal neurons. The present study was carried out to investigate the effect of MeHg on cysteine uptake in both astrocytes and neurons, and to determine whether cysteine transport is differentially affected in the two cell types by MeHg treatment. Sixty-minute pretreatment with MeHg caused significant concentration-dependent inhibition in cysteine uptake in astrocytes, but not in neurons. As most of the cysteine transport is Na+-dependent (80-90% of total), additional studies focused on MeHg's effect on the Na+-dependent cysteine transporters XAG- and ASC. An additive inhibitory effect on cysteine uptake was observed in astrocytes treated with MeHg (5 μM) plus sub-maximal inhibitory concentrations (0.1 and 0.5 mM) of threo-β-hydroxy-aspartate (THA), a specific inhibitor of the Na+-dependent transporter, XAG-, compared to astrocytes treated with MeHg (P<0.001) or THA alone (P<0.05). There was no additive effect of MeHg and maximal inhibitory concentrations of THA (1.0 and 5.0 mM) on astrocytic cysteine uptake inhibition. Additional studies examined the sensitivity of the Na+-dependent ASC transport system to MeHg treatment. Maximal inhibitory concentration of L-serine (10 mM) alone had a rather modest inhibitory effect on cysteine uptake, and when applied in the presence of MeHg there was no additive effect. These results suggest that the inhibition of cysteine uptake by MeHg in astrocytes occurs through specific inhibition of both the XAG- as well as the ASC transport system.

AB - The maintenance of adequate intracellular glutathione (GSH) concentrations is dependent on the availability and transport of the rate-limiting substrate, cysteine. A suggested mechanism of methylmercury (MeHg) neurotoxicity in brain involves the formation of oxygen radicals, and a decrease in intracellular levels of GSH. Recently, we have characterized various cysteine transport systems (both Na+-dependent and -independent) in cerebrocortical astrocytes and hippocampal neurons. The present study was carried out to investigate the effect of MeHg on cysteine uptake in both astrocytes and neurons, and to determine whether cysteine transport is differentially affected in the two cell types by MeHg treatment. Sixty-minute pretreatment with MeHg caused significant concentration-dependent inhibition in cysteine uptake in astrocytes, but not in neurons. As most of the cysteine transport is Na+-dependent (80-90% of total), additional studies focused on MeHg's effect on the Na+-dependent cysteine transporters XAG- and ASC. An additive inhibitory effect on cysteine uptake was observed in astrocytes treated with MeHg (5 μM) plus sub-maximal inhibitory concentrations (0.1 and 0.5 mM) of threo-β-hydroxy-aspartate (THA), a specific inhibitor of the Na+-dependent transporter, XAG-, compared to astrocytes treated with MeHg (P<0.001) or THA alone (P<0.05). There was no additive effect of MeHg and maximal inhibitory concentrations of THA (1.0 and 5.0 mM) on astrocytic cysteine uptake inhibition. Additional studies examined the sensitivity of the Na+-dependent ASC transport system to MeHg treatment. Maximal inhibitory concentration of L-serine (10 mM) alone had a rather modest inhibitory effect on cysteine uptake, and when applied in the presence of MeHg there was no additive effect. These results suggest that the inhibition of cysteine uptake by MeHg in astrocytes occurs through specific inhibition of both the XAG- as well as the ASC transport system.

KW - Astrocytes

KW - Cysteine

KW - Glutathione

KW - In vitro

KW - Methlmercury

KW - Neurons

KW - Transport

UR - http://www.scopus.com/inward/record.url?scp=0035964767&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035964767&partnerID=8YFLogxK

U2 - 10.1016/S0006-8993(01)02791-3

DO - 10.1016/S0006-8993(01)02791-3

M3 - Article

C2 - 11578608

AN - SCOPUS:0035964767

VL - 914

SP - 159

EP - 165

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 1-2

ER -